CGON

Cg Oncology Stock Analysis

AI Rating

Low
  • Quality5/10
  • Growth↓ 4/10
  • Value↓ 0/10
Cg Oncology sales and earnings growth
CGON Growth
Neutral
  • Revenue Y/Y↑ 254.70%
  • EPS Y/Y↓ -47.52%
  • FCF Y/Y↓ -67.81%
Cg Oncology gross and profit margin trends
CGON Profitability
Neutral
  • Gross margin ↓ -15.00%
  • EPS margin↓ -3985.00%
  • ROIC 5Y↓ 0.00%
Cg Oncology net debt vs free cash flow
CGON Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Cg Oncology stock volatility is higher than the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗